<DOC>
	<DOCNO>NCT02239133</DOCNO>
	<brief_summary>The study include five ( 5 ) main stage : Screening , Enrollment , Size fitting , Usage Termination . Subject screen hold visit one ( 1 ) visit two ( 2 ) clinic . Initiation Size fitting : All eligible subject undergo size fit gynecologist / urogynecologist , visit 2 , find suitable size . The subject use ProVATE device chosen size clinic vicinity one ( 1 ) hour 40-80 hour home environment , confirm choose size appropriate user . Each usage follow vaginal examination . In case investigator determine subject fit different size ProVATE device subject repeat stage different device size suitable size confirm investigator . Usage : The subject use ProVATE device least 28 day 45 day period , home environment , fill usage diary . Each device use least 24 hour . At least one ( 1 ) follow-up phone call hold subject per week . After 14 usage day follow least two ( 2 ) usage ( late ) subject schedule vaginal examination clinic ( visit four ( 4 ) ) . End Of Use At end use subject return clinic ( visit five ( 5 ) ) vaginal examination additional activity . The following questionnaire fill baseline end study : Quality Of Life ( QoL ) POP symptom . Satisfaction Ease Of Use questionnaire fill end use ( visit 5 ) Up four ( 4 ) ProVATE device model test study .</brief_summary>
	<brief_title>R &amp; D Supporting Pilot Study Assessment Safety Effectiveness ProVATE ( ProTIPI ) Vaginal Pessary</brief_title>
	<detailed_description />
	<mesh_term>Prolapse</mesh_term>
	<mesh_term>Pelvic Organ Prolapse</mesh_term>
	<criteria>Females age 2180 year Ability use hand insert device vagina Ability attend study site explain investigator A symptomatic sensation vaginal prolapse The subject ability understand nature study sign inform consent On examination , presence vaginal wall prolapse one sit On examination , POPQ grade 2 4 POP demonstrate A 6191 mm pessary well fit A 6191 mm pessary well retain Previous inability accommodate tampon vaginal pessary Subject currently participate another clinical study may directly indirectly affect result study Comorbid condition ( ) severe systemic disease could limit subject 's ability participate study , impact scientific integrity study Subject pregnant , suspect pregnant planning pregnant course study Abnormal vaginal bleeding past 6 month Previous vaginal surgery last 3 month A severely atrophic vagina Existing vaginal vulvar laceration Symptomatic vaginal infection determine physical examination lab result Symptomatic urinary tract infection determine physical examination lab result Recurrent urinary tract infection Abnormal cervical cytology</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Pelvic Organ Prolapse</keyword>
	<keyword>POP</keyword>
</DOC>